New triple therapy shows promise in shrinking advanced stomach tumors before surgery
Disease control
Recruiting now
This study tests whether adding an immune-boosting drug (thymalfasin) to standard chemotherapy and immunotherapy can help shrink stage III stomach or gastroesophageal junction cancer before surgery. About 30 adults aged 18-75 will receive the combination, then have their tumor ti…
Phase: PHASE2 • Sponsor: Zekuan Xu • Aim: Disease control
Last updated Jun 27, 2026 09:09 UTC